Patents by Inventor Jay D. Keasling

Jay D. Keasling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8114645
    Abstract: The present invention provides methods of increasing production of an isoprenoid or an isoprenoid precursor in a host cell, the methods generally involving modulating the level of activity of a fatty acid biosynthetic pathway enzyme in the host cell and/or culturing the host cell in a culture medium comprising a fatty acid or a compound that can be metabolized in a cell or broken down in the medium to yield a fatty acid and/or culturing the host cell in a culture medium having increased osmolarity.
    Type: Grant
    Filed: May 17, 2007
    Date of Patent: February 14, 2012
    Assignee: The Regents of the University of California
    Inventors: Douglas J. Pitera, Jack D. Newman, Jeffrey Lance Kizer, Jay D. Keasling, Brian F. Pfleger
  • Patent number: 8101399
    Abstract: The present invention provides artemisinic epoxide, and methods of synthesizing artemisinic epoxide in a genetically modified host cell. The present invention further provides methods for producing artemisinin. The present invention further provides variant enzymes that catalyze the oxidation of amorpha-4,11-diene to artemisinic epoxide; nucleic acids encoding the variant enzymes; as well as recombinant vectors and host cells comprising the nucleic acids.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: January 24, 2012
    Assignee: The Regents of the University of California
    Inventors: Jeffrey Allen Dietrich, Yasuo Yoshikuni, Jay D. Keasling, Michelle Chia-Yu Chang
  • Patent number: 8097438
    Abstract: The present invention provides nucleic acids comprising nucleotide sequences encoding modified cytochrome P450 enzymes; as well as recombinant vectors and host cells comprising the nucleic acids. The present invention further provides methods of producing a functionalized compound in a host cell genetically modified with a nucleic acid comprising nucleotide sequences encoding a modified cytochrome P450 enzyme.
    Type: Grant
    Filed: October 5, 2006
    Date of Patent: January 17, 2012
    Assignee: The Regents of the University of California
    Inventors: Michelle Chia-Yu Chang, Rachel A. Krupa, Dae-Kyun Ro, Yasuo Yoshikuni, Jay D. Keasling
  • Publication number: 20110294183
    Abstract: The present invention provides for a modified host cell comprising a heterologous expression of an efflux pump capable of transporting an organic molecule out of the host cell wherein the organic molecule at a sufficiently high concentration reduces the growth rate of or is lethal to the host cell.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Mary J. Dunlop, Jay D. Keasling, Aindrila Mukhopadhyay
  • Patent number: 7985567
    Abstract: The invention provides for a method for producing a 5-carbon alcohol in a genetically modified host cell. In one embodiment, the method comprises culturing a genetically modified host cell which expresses a first enzyme capable of catalyzing the dephosphorylation of an isopentenyl pyrophosphate (IPP) or dimethylallyl diphosphate (DMAPP), such as a Bacillus subtilis phosphatase (YhfR), under a suitable condition so that 5-carbon alcohol is 3-methyl-2-buten-1-ol and/or 3-methyl-3-buten-1-ol is produced. Optionally, the host cell may further comprise a second enzyme capable of reducing a 3-methyl-2-buten-1-ol to 3-methyl-butan-1-ol, such as a reductase.
    Type: Grant
    Filed: December 23, 2009
    Date of Patent: July 26, 2011
    Assignee: The Regents of the University of California
    Inventors: Howard H. Chou, Jay D. Keasling
  • Publication number: 20110097769
    Abstract: The invention provides a genetically modified microorganism that acquires the ability to consume a renewable feedstock (such as cellulose) and produce products. This organism can be used to ferment cellulose, one of the most abundant renewable resources available, and produce products.
    Type: Application
    Filed: February 13, 2007
    Publication date: April 28, 2011
    Inventors: Stephen B. Del Cardayre, Shane Brubaker, Jay D. Keasling
  • Patent number: 7927794
    Abstract: The present invention provides isolated, genetically modified host cells, where a host cell is genetically modified with a nucleic acid that includes a nucleotide sequence encoding a biosynthetic pathway enzyme. Synthesis of the enzyme in the host cell results in conversion of a substrate for the enzyme into a biosynthetic pathway intermediate, which intermediate is produced in an amount effective to inhibit growth of the genetically modified host cell. The present invention further provides compositions and kits comprising a subject genetically modified host cell. Subject host cells are useful for identifying a gene product having activity in a biosynthetic pathway. The present invention further provides methods of identifying a gene product having activity in a biosynthetic pathway.
    Type: Grant
    Filed: September 29, 2004
    Date of Patent: April 19, 2011
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, Jack D. Newman, Douglas J. Pitera, Sydnor T. Withers, III, Keith Kinkead Reiling, Vincent J. J. Martin
  • Patent number: 7915026
    Abstract: Methods for synthesizing isopentenyl pyrophosphate are provided. A first method comprises introducing into a host microorganism a plurality of heterologous nucleic acid sequences, each coding for a different enzyme in the mevalonate pathway for producing isopentenyl pyrophosphate. A related method comprises introducing into a host microorganism an intermediate in the mevalonate pathway and at least one heterologous nucleic acid sequence, each sequence coding for an enzyme in the mevalonate pathway necessary for converting the intermediate into isopentenyl pyrophosphate. The invention also provides nucleic acid sequences, enzymes, expression vectors, and transformed host cells for carrying out the methods.
    Type: Grant
    Filed: October 8, 2009
    Date of Patent: March 29, 2011
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, Vincent J. J. Martin, Douglas J. Pitera, Seon-Won Kim, Sydnor T. Withers, III, Yasuo Yoshikuni, Jack Newman, Artem Valentinovich Khlebnikov
  • Publication number: 20110065105
    Abstract: The present invention provides for a system comprising a BmoR transcription factor, a ?54-RNA polymerase, and a pBMO promoter operatively linked to a reporter gene, wherein the pBMO promoter is capable of expression of the reporter gene with an activated form of the BmoR and the ?54-RNA polymerase.
    Type: Application
    Filed: April 26, 2010
    Publication date: March 17, 2011
    Applicant: The Regents of the University of California
    Inventors: Jeffrey A. Dietrich, Jay D. Keasling
  • Publication number: 20110039291
    Abstract: The present invention provides a method comprising the use of microorganisms for nanotoxicity study and bioremediation. In some embodiment, the microorganisms are bacterial organisms such as Gram negative bacteria, which are used as model organisms to study the nanotoxicity of the fullerene compounds: E. coli W3110, a human related enterobacterium and Shewanella oneidensis MR-1, an environmentally important bacterium with versatile metabolism.
    Type: Application
    Filed: February 5, 2008
    Publication date: February 17, 2011
    Inventors: Frank Fanqing Chen, Jay D. Keasling, Yinjie J. Tang
  • Patent number: 7888095
    Abstract: The present invention provides methods of designing and generating polypeptide variants that have altered function compared to a parent polypeptide. The present invention further provides a computer program product for carrying out the design of a variant polypeptide. The present invention further provides nucleic acids encoding terpene cyclase variants, as well as vectors and host cells comprising the nucleic acids. The present invention further provides variant terpene cyclases; methods of producing the variant terpene cyclases; and methods of producing isoprenoid compounds.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: February 15, 2011
    Assignee: The Regents of the University of California
    Inventors: Jay D. Keasling, Yasuo Yoshikuni
  • Publication number: 20110021790
    Abstract: The present invention provides for a non-naturally occurring polyketide synthase (PKS) capable of synthesizing a carboxylic acid or a lactone, and a composition such that a carboxylic acid or lactone is included. The carboxylic acid or lactone, or derivative thereof, is useful as a biofuel. The present invention also provides for a recombinant nucleic acid or vector that encodes such a PKS, and host cells which also have such a recombinant nucleic acid or vector. The present invention also provides for a method of producing such carboxylic acids or lactones using such a PKS.
    Type: Application
    Filed: April 29, 2009
    Publication date: January 27, 2011
    Applicant: The Regents of the University of California
    Inventors: Leonard Katz, Jeffrey L. Fortman, Jay D. Keasling
  • Publication number: 20110014667
    Abstract: The present invention provides for a polyketide synthase (PKS) capable of synthesizing a dicarboxylic acid (diacid). Such diacids include diketide-diacids and triketide-diacids. The invention includes recombinant nucleic acid encoding the PKS, and host cells comprising the PKS. The invention also includes methods for producing the diacids.
    Type: Application
    Filed: March 30, 2009
    Publication date: January 20, 2011
    Applicant: The Regents of the University of California
    Inventors: Leonard Katz, Jeffrey L. Fortman, Jay D. Keasling
  • Publication number: 20110008829
    Abstract: The present invention provides methods of producing a product or product precursor of a biosynthetic pathway in a genetically modified host cell. The present invention also provides genetically modified host cells comprising nucleic acids encoding a scaffold polypeptide and nucleic acids comprising nucleotide sequences encoding two or more enzymes in a biosynthetic pathway. The present invention further provides nucleic acids comprising nucleotide sequences encoding scaffold polypeptides, for use in a subject method.
    Type: Application
    Filed: February 26, 2009
    Publication date: January 13, 2011
    Inventors: John E. Dueber, Jay D. Keasling, Gabriel C. Wu, Ghulam Reza Kahn Malmirchegini
  • Publication number: 20100242345
    Abstract: Genetically engineered microorganisms are provided that produce products from the fatty acid biosynthetic pathway (fatty acid derivatives), as well as methods of their use.
    Type: Application
    Filed: May 18, 2007
    Publication date: September 30, 2010
    Applicant: LS9, Inc
    Inventors: Jay D. Keasling, Zhihao Hu, Chris Sommerville, George Church, David Berry, Lisa Friedman, Andreas Schirmer, Shane Brubaker, Stephen B. del Cardayre
  • Publication number: 20100218283
    Abstract: The present invention provides isolated nucleic acids comprising nucleotide sequences encoding isoprenoid modifying enzymes, as well as recombinant vectors comprising the nucleic acids. The present invention further provides genetically modified host cells comprising a subject nucleic acid or recombinant vector. The present invention further provides a transgenic plant comprising a subject nucleic acid. The present invention further provides methods of producing an isoprenoid compound, the method generally involving culturing a subject genetically modified host cell under conditions that permit synthesis of an isoprenoid compound modifying enzyme encoded by a subject nucleic acid.
    Type: Application
    Filed: June 29, 2006
    Publication date: August 26, 2010
    Inventors: Dae-Kyun Ro, Karyn Newman, Eric M. Paradise, Jay D. Keasling, Mario Ouellet, Rachel Eachus, Kimberly Ho, Timothy Ham
  • Publication number: 20100205855
    Abstract: The invention provides for a method for producing a 5-carbon alcohol in a genetically modified host cell. In one embodiment, the method comprises culturing a genetically modified host cell which expresses a first enzyme capable of catalyzing the dephosphorylation of an isopentenyl disphosphate (IPP) or dimethylallyl diphosphate (DMAPP), such as a Bacillus subtilis phosphatase (YhfR), under a suitable condition so that 5-carbon alcohol is 3-methyl-2-buten-1-ol and/or 3-methyl-3-buten-1-ol is produced. Optionally, the host cell may further comprise a second enzyme capable of reducing a 3-methyl-2-buten-1-ol to 3-methyl-butan-1-ol, such as a reductase.
    Type: Application
    Filed: December 23, 2009
    Publication date: August 19, 2010
    Applicant: The Regents of the University of California
    Inventors: Howard H. Chou, Jay D. Keasling
  • Publication number: 20100180491
    Abstract: The invention provides for a method of producing an isoprenyl alkanoate in a genetically modified host cell. In one embodiment, the method comprises culturing a genetically modified host cell which expresses an enzyme capable of catalyzing the esterification of an isoprenol and a straight-chain fatty acid, such as an alcohol acetyltransferase (AAT), wax ester synthase/diacylglycerol acyltransferase (WS/DGAT) or lipase, under a suitable condition so that the isoprenyl alkanoate is produced.
    Type: Application
    Filed: December 22, 2009
    Publication date: July 22, 2010
    Applicant: The Regents of the University of California
    Inventors: Taek Soon Lee, Jeffrey L. Fortman, Jay D. Keasling
  • Publication number: 20100170148
    Abstract: The present invention provides for a method of producing one or more fatty acid derived compounds in a genetically modified host cell which does not naturally produce the one or more derived fatty acid derived compounds. The invention provides for the biosynthesis of fatty acid derived compounds such as C18 aldehydes, C18 alcohols, C18 alkanes, and C17 alkanes from C18-CoA which in turn is synthesized from butyryl-CoA. The host cell can be further modified to increase fatty acid production or export of the desired fatty acid derived compound, and/or decrease fatty acid storage or metabolism.
    Type: Application
    Filed: December 21, 2009
    Publication date: July 8, 2010
    Applicant: The Regents of the University of California
    Inventors: Eric J. Steen, Jay D. Keasling
  • Publication number: 20100173367
    Abstract: The present invention provides functionalized molecules comprising a covalently linked autosilification moiety; and methods for making and using the functionalized molecules. The present invention provides nucleic acids comprising nucleotide sequence encoding polypeptides comprising an autosilification moiety. The present invention further provides silica matrices comprising a subject functionalized molecule, as well as systems and kits comprising the silica matrices. The subject functionalized molecules find use in various applications, which are also provided.
    Type: Application
    Filed: October 26, 2007
    Publication date: July 8, 2010
    Inventors: Wesley D. Marner, II, Afshan S. Shaikh, Jay D. Keasling, William J. Holtz, Sydnor T. Withers, III, Jeffery L. Kizer